Allscripts Healthcare Stock
Your prediction
Allscripts Healthcare Stock
Heavy losses for Allscripts Healthcare today as the stock fell by -€0.600 (-15.000%).
Pros and Cons of Allscripts Healthcare in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allscripts Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allscripts Healthcare | -15.000% | 17.647% | 11.111% | -6.977% | 11.111% | -74.194% | -71.014% |
| Simulations Plus | -8.510% | -16.071% | -8.442% | -61.892% | -8.442% | -61.892% | -79.565% |
| MicroVision Inc | 0.280% | -19.385% | -19.597% | -54.951% | -18.306% | -79.818% | -92.066% |
| Fonar Corp. New | 0.000% | 0.000% | -0.637% | 4.000% | 0.000% | -4.294% | 4.000% |
Comments
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at TD Cowen from $26.00 to $15.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at Royal Bank of Canada from $22.00 to $11.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat